1-7 of 7
James M. Foran
Close
Sort by
Journal Articles

Molecular and Clinical Characterization of ETNK1-mutated Myeloid Neoplasms: The Mayo Clinic Experience

Steven Tessier, Rong He, Patricia T. Greipp, David S Viswanatha, Kurt R Bessonen, Terra L Lasho, James M Foran, Cecilia Arana-Yi, Naseema Gangat, Ayalew Tefferi, Mithun Vinod Shah, Hassan B Alkhateeb, Shujun Liu, Animesh D Pardanani, Mrinal M. Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv bloodadvances.2024013255.
https://doi.org/10.1182/bloodadvances.2024013255
Published: 2024
Includes: Supplemental data
Journal Articles

Final phase I substudy results of ivosidenib in patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

Clinical Trials & Observations
Courtney D. D DiNardo, Gail J. Roboz, Justin M Watts, Yazan F Madanat, Gabrielle T. Prince, Praneeth Baratam, Stéphane de Botton, Anthony S. Stein, James M Foran, Martha L. Arellano, David A Sallman, Mohammad Hossain, Dylan M. Marchione, Xiaofei Bai, Prapti A. Patel, Stephanie M. Kapsalis, Guillermo Garcia-Manero, Amir T. Fathi
Journal: Blood Advances
Blood Adv bloodadvances.2023012302.
https://doi.org/10.1182/bloodadvances.2023012302
Published: 2024
Includes: Supplemental data
Journal Articles

A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2 -mutant AML

Clinical Trials & Observations
Sheng F. Cai, Ying Huang, Jennie R. Lance, Hsiaoyin Charlene Mao, Andrew J. Dunbar, Samantha N. McNulty, Todd Druley, Yan Li, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William G. Blum, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark Litzow, Tara Lin, Prapti Patel, Matthew C. Foster, Michael Boyiadzis, Robert H. Collins, Jordan Chervin, Abigail Shoben, Jo-Anne Vergilio, Nyla A. Heerema, Leonard Rosenberg, Timothy L. Chen, Ashley O. Yocum, Franchesca Druggan, Sonja Marcus, Mona Stefanos, Brian J. Druker, Alice S. Mims, Uma Borate, Amy Burd, John C. Byrd, Ross L. Levine, Eytan M. Stein
Journal: Blood Advances
Blood Adv (2024) 8 (2): 429–440.
https://doi.org/10.1182/bloodadvances.2023010563
Published: 2024
Includes: Supplemental data
Journal Articles

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Clinical Trials & Observations
Edward J. Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu, Rafael Bejar, Steven D. Gore, Steven H. Kroft, Alexandra Harrington, Wael Saber, Daniel Starczynowski, Dana E. Rollison, Ling Zhang, Lynn Moscinski, Steffanie Wilson, Jason Thompson, Christine Borchert, Seth Sherman, Donnie Hebert, Mary Ellen Walker, Eric Padron, Amy E. DeZern, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6120–6129.
https://doi.org/10.1182/bloodadvances.2023010061
Published: 2023
Includes: Supplemental data
Journal Articles

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Clinical Trials & Observations
Gregory A. Abel, Donnie Hebert, Cecilia Lee, Dana Rollison, Nancy Gillis, Rami Komrokji, James M. Foran, Jane Jijun Liu, Tareq Al Baghdadi, Joachim Deeg, Steven Gore, Wael Saber, Steffanie Wilson, Michael Otterstatter, Jason Thompson, Christine Borchert, Eric Padron, Amy DeZern, David Cella, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3506–3515.
https://doi.org/10.1182/bloodadvances.2022009000
Published: 2023
Includes: Supplemental data
Journal Articles

Pevonedistat with azacitidine in older patients with TP53 -mutated AML: a phase 2 study with laboratory correlates

Clinical Trials & Observations
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2360–2363.
https://doi.org/10.1182/bloodadvances.2022008625
Published: 2023
Includes: Supplemental data
Journal Articles

Genetic features and clinical outcomes of patients with isolated and comutated DDX41 -mutated myeloid neoplasms

Hassan B. Alkhateeb, Ahmad Nanaa, David Viswanatha, James M. Foran, Talha Badar, Lisa Sproat, Rong He, Phuong Nguyen, Dragan Jevremovic, Mohamad E. Salama, Patricia Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2022) 6 (2): 528–532.
https://doi.org/10.1182/bloodadvances.2021005738
Published: 2022
Includes: Supplemental data